FY25 consensus $3.76. Raises full-year 2025 revenue growth range 50 basis points to 8.5%-9.5% on a constant-currency basis and 9.5%-10.5% on an organic basis. FY25 consensus $1.37B.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIVN:
- LIVN Earnings this Week: How Will it Perform?
- LivaNova’s VNS Therapy Study: A Potential Game-Changer for Depression Treatment
- LivaNova’s VNS Therapy Study: A Potential Game-Changer for Treatment-Resistant Depression
- Apple initiated, DraftKings downgraded: Wall Street’s top analyst calls
- LivaNova downgraded to Neutral from Buy at Goldman Sachs